By Kate Ruder for KFF Health News. Broadcast version by Eric Galatas for Colorado News Connection reporting for the KFF ...

In particular, use of the hallucinogenic substance increased by 44 percent in 2023 among young adults aged between 18 and 29.

Taking LSD or magic mushrooms may not be the cause of schizotypal traits. Psychedelic drugs are experiencing a resurgence of ...

The Cleveland Clinic is part of a multisite trial studying psilocybin to help patients with treatment-resistant depression.

Psychedelic drugs, like the psilocybin found in the mushrooms, disrupt neural activity in the brain and cause cognitive and ...

A UW-Madison study using psilocybin to treat opioid use disorder is already giving some people new leases on life.

Bendable Therapy announced this week it will now accept insurance through Enthea, the only licensed benefits provider ...

Psychedelic drugs are seeing a surge of interest from mainstream medicine, and initial results suggest that ...

The Department of Veterans ­Affairs will fund MDMA and ­psilocybin-assisted therapies for veterans with post-traumatic stress ...